Investigators compared trial demographics against baseline electronic health record data at 3 NCI–designated cancer centers to identify enrollment gaps.

Clinical trial enrollment is vital for advancing renal cell carcinoma treatment, providing access to innovative therapies and potentially better care. The STELLAR-002 study evaluated zanzalintinib ...

Education-centric outreach strengthens cognitive trust but underperforms when sponsor engagement is transactional and not ...

A new study out from the Tufts Center for the Study of Drug Development (CSDD) indicates that it is difficult for companies to start up and enroll patients into clinical trials, with many trials ...

Spun out from Splash Clinical, SplashBIO™ brings biomarker pre-screening to the front of the clinical trial — built to reduce screen failures and accelerate enrollment. The newly independent company ...

Breast cancer is the most-researched disease, yet only 14% of trials reach optimal enrollment, highlighting a significant gap in clinical trial participation. COVID-19 has increased trial attrition ...

Antidote Technologies, a digital patient engagement company, announced it is partnering with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve ...

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...

Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic condition. Although she identified several promising trials, she found the ...

Susan Vadaparampil, PhD, MPH, explains that aligning clinical trials with community needs can improve enrollment diversity. What is a common misconception about diverse clinical trial enrollment that ...

APEX 24-week Phase 2 trial is evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF)APEX Phase 2 ...